{"id":"W4376613526","doi":"10.1016/j.esmoop.2023.101342","title":"118P Real-world treatment patterns and clinical outcomes among high risk, early stage HER2-negative breast cancer (BC) patients in Alberta, Canada","year":2023,"lang":"en","type":"article","venue":"ESMO Open","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada); University of Calgary","funders":"Chinese Academy of Medical Sciences; AstraZeneca; Les Laboratories Pierre Fabre; Academy of Medical Sciences; Chinese Academy of Sciences; Cancer Research Institute","keywords":"Medicine; Breast cancer; Cumulative incidence; Stage (stratigraphy); Population; Internal medicine; Cancer registry; Epidemiology; Hormone therapy; Incidence (geometry); Oncology; Adjuvant therapy; Cohort; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005136472,0.000224164,0.0003119709,0.001320612,0.001591458,0.001305438,0.0009187864,0.0003422858,0.002104308],"category_scores_gemma":[0.001523037,0.000255285,0.0003829433,0.003955875,0.0005322892,0.0002656046,0.0005533426,0.0004439229,0.0002809702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02172917,"about_ca_system_score_gemma":0.01784397,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9904883,"about_ca_topic_score_gemma":0.9928884,"domain_scores_codex":[0.9993436,0.00006100998,0.00004383347,0.0001141362,0.0001983272,0.000239072],"domain_scores_gemma":[0.9985029,0.00008830414,0.0003456505,0.00007116363,0.000648569,0.0003434824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004553356,0.00001873369,0.9966525,0.00001419947,0.00002741139,0.00004725332,0.000117332,0.00009680459,0.00006641865,0.00003680752,0.0009770514,0.001899785],"study_design_scores_gemma":[0.000008088153,0.00001541992,0.9985465,0.00001744835,0.00001766084,0.0000689228,0.0004158503,0.0002042906,0.00002752366,0.00001737651,0.0006544571,0.00000636624],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854615,0.0008294646,0.0001428098,0.0003310994,0.00001724874,0.00005970413,0.01046933,0.00001684009,0.002672046],"genre_scores_gemma":[0.9949296,0.0003431794,0.00020049,0.0001363366,0.000007511055,0.00002078243,0.003407393,0.000005461387,0.0009493963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02172917,"threshold_uncertainty_score":0.1576569,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.015835592691497,"score_gpt":0.3128743880217857,"score_spread":0.2970387953302888,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}